Literature DB >> 26052099

Decreased expression of mGluR5 within the dorsolateral prefrontal cortex in autism and increased microglial number in mGluR5 knockout mice: Pathophysiological and neurobehavioral implications.

Gursharan Chana1, Liliana Laskaris2, Christos Pantelis3, Piers Gillett2, Renee Testa4, Daniela Zantomio5, Emma L Burrows6, Anthony J Hannan7, Ian P Everall8, Efstratios Skafidas2.   

Abstract

Metabotropic glutamate receptor 5 (mGluR5) and microglial abnormalities have been implicated in autism spectrum disorder (ASD). However, controversy exists as to whether the receptor is down or upregulated in functioning in ASD. In addition, whilst activation of mGluR5 has been shown to attenuate microglial activation, its role in maintaining microglial homeostasis during development has not been investigated. We utilised published microarray data from the dorsolateral prefrontal cortex (DLPFC) of control (n=30) and ASD (n=27) individuals to carry out regression analysis to assess gene expression of mGluR5 downstream signalling elements. We then conducted a post-mortem brain stereological investigation of the DLPFC, to estimate the proportion of mGluR5-positive neurons and glia. Finally, we carried out stereological investigation into numbers of microglia in mGluR5 knockout mice, relative to wildtype littermates, together with assessment of changes in microglial somal size, as an indicator of activation status. We found that gene expression of mGluR5 was significantly decreased in ASD versus controls (p=0.018) as well as downstream elements SHANK3 (p=0.005) and PLCB1 (p=0.009) but that the pro-inflammatory marker NOS2 was increased (p=0.047). Intensity of staining of mGluR5-positive neurons was also significantly decreased in ASD versus controls (p=0.016). Microglial density was significantly increased in mGluR5 knockout animals versus wildtype controls (p=0.011). Our findings provide evidence for decreased expression of mGluR5 and its signalling components representing a key pathophysiological hallmark in ASD with implications for the regulation of microglial number and activation during development. This is important in the context of microglia being considered to play key roles in synaptic pruning during development, with preservation of appropriate connectivity relevant for normal brain functioning.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autism; Glutamate; Microglia; Neuroinflammation; Neuropathology; Stereology

Mesh:

Substances:

Year:  2015        PMID: 26052099     DOI: 10.1016/j.bbi.2015.05.009

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  13 in total

1.  Resveratrol Improves Neuroimmune Dysregulation Through the Inhibition of Neuronal Toll-Like Receptors and COX-2 Signaling in BTBR T+ Itpr3tf/J Mice.

Authors:  Sheikh F Ahmad; Mushtaq A Ansari; Ahmed Nadeem; Mohammad Z Alzahrani; Saleh A Bakheet; Sabry M Attia
Journal:  Neuromolecular Med       Date:  2018-02-21       Impact factor: 3.843

2.  Genetic disruption of Grm5 causes complex alterations in motor activity, anxiety and social behaviors.

Authors:  Jian Xu; John J Marshall; Stephen Kraniotis; Toshihiro Nomura; Yongling Zhu; Anis Contractor
Journal:  Behav Brain Res       Date:  2021-05-21       Impact factor: 3.352

3.  Postmortem Studies of Neuroinflammation in Autism Spectrum Disorder: a Systematic Review.

Authors:  Xiaoli Liao; Yiting Liu; Xi Fu; Yamin Li
Journal:  Mol Neurobiol       Date:  2020-06-11       Impact factor: 5.682

Review 4.  Neuroinflammation in Autism: Plausible Role of Maternal Inflammation, Dietary Omega 3, and Microbiota.

Authors:  Charlotte Madore; Quentin Leyrolle; Chloé Lacabanne; Anouk Benmamar-Badel; Corinne Joffre; Agnes Nadjar; Sophie Layé
Journal:  Neural Plast       Date:  2016-10-20       Impact factor: 3.599

Review 5.  Variation in Gene Expression in Autism Spectrum Disorders: An Extensive Review of Transcriptomic Studies.

Authors:  Ashley Ansel; Joshua P Rosenzweig; Philip D Zisman; Michal Melamed; Benjamin Gesundheit
Journal:  Front Neurosci       Date:  2017-01-05       Impact factor: 4.677

6.  No preliminary evidence of differences in astrocyte density within the white matter of the dorsolateral prefrontal cortex in autism.

Authors:  Ian Everall; Gursharan Chana; Ting Ting Lee; Efstratios Skafidas; Mirella Dottori; Daniela Zantomio; Christos Pantelis
Journal:  Mol Autism       Date:  2017-12-08       Impact factor: 7.509

7.  Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice.

Authors:  C Vicidomini; L Ponzoni; D Lim; M J Schmeisser; D Reim; N Morello; D Orellana; A Tozzi; V Durante; P Scalmani; M Mantegazza; A A Genazzani; M Giustetto; M Sala; P Calabresi; T M Boeckers; C Sala; C Verpelli
Journal:  Mol Psychiatry       Date:  2016-03-29       Impact factor: 15.992

8.  Metabotropic glutamate receptor 5 tracer [18F]-FPEB displays increased binding potential in postcentral gyrus and cerebellum of male individuals with autism: a pilot PET study.

Authors:  S Hossein Fatemi; Dean F Wong; James R Brašić; Hiroto Kuwabara; Anil Mathur; Timothy D Folsom; Suma Jacob; George M Realmuto; José V Pardo; Susanne Lee
Journal:  Cerebellum Ataxias       Date:  2018-02-12

Review 9.  Pathogenetical and Neurophysiological Features of Patients with Autism Spectrum Disorder: Phenomena and Diagnoses.

Authors:  Yunho Jin; Jeonghyun Choi; Seunghoon Lee; Jong Won Kim; Yonggeun Hong
Journal:  J Clin Med       Date:  2019-10-02       Impact factor: 4.241

10.  Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study.

Authors:  James Robert Brašić; Ayon Nandi; David S Russell; Danna Jennings; Olivier Barret; Samuel D Martin; Keith Slifer; Thomas Sedlak; John P Seibyl; Dean F Wong; Dejan B Budimirovic
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.